A major stem cell therapy trial for Parkinson's disease has finished enrolling participants, marking a critical milestone in experimental treatment research.
Read more →
A $6 million grant to Banner Sun Health accelerates the development of blood tests that could identify Parkinson's disease earlier than current clinical methods.
Read more →
Phase 1b/2a trial enrollment completion signals progress in evaluating RNDP-001, but approval remains years away.
Read more →
Scientists are investigating whether restoring healthy gut bacteria could slow or prevent Parkinson's disease.
Read more →
FDA approval of new delivery methods and dozens of emerging Parkinson's therapies in clinical trials are reshaping treatment options in 2026.
Read more →
A major 2026 Mexican study identified 32 genetic variants linked to Parkinson's disease, shifting understanding of genetic risk in understudied populations.
Read more →
Parkinson's disease emerges from overlapping genetic, environmental, and age-related factors rather than a single cause.
Read more →
How clinical trials work in Parkinson's disease, where to find them (ClinicalTrials.gov, Fox Trial Finder, PPMI), what to expect, and what questions to ask.
Read more →